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A straightforward approach toward 6-bromo-2-isopropylidenecoumaranone, a potential intermediate toward alkaloid TMC
120-B, pseudodeflectusin, and other natural products, was reported. The synthetic sequence involved the reaction of
3-bromosalicylaldehyde with chloroacetone and cyclization of the resulting ether to a 2-acetylcoumaranol intermediate. This
was followed by sequential methyl Grignard addition and Jones’ oxidation to the corresponding coumaranone, which was
dehydrated to the final product with the methanesulfonyl chloride/pyridine reagent. The protection of the coumaranol as the
corresponding THP-ether resulted in improved product yields.
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Introduction
The benzofuran framework, consisting of fused benzene
and furan rings, has been identified as a privileged core
structure [1]. Naturally occurring 2-methylene-3-benzofur-
anones comprise a series of compounds, widely spread in
species of higher plants [2 – 4], which display interesting
biological activities; among them, they are antiprotozoan
[5] and anti-cancer [6] agents.
The more elaborated 2-isopropylidenecoumaranone
motif is present in a smaller range of natural products iso-
lated, to date, exclusively from the Asteraceae family of
plants. In addition, some 2-isopropylidenecoumaranones
were obtained from fungi, whereas compounds bearing
this feature have also been used as valuable synthetic
intermediates.
Thus, among the plant-derived compounds, the hete-
rocyclic alcohols 1 and 2 were found in Verbesina luetsel-
hurgii MATTF. and Oyedaea boliviana, respectively [4][7],
whereas the related ester 3 was obtained from the leaves
of both, Enceliopsis couillei and E. argophylla [3][8]. The
latter plant also provided the congeneric esters 4 – 7.
Further, the 5-acetylcoumaranone derivative 8 has
been isolated from the perennial herbs Ligularia
kongkalingensis and L. nelumbifolia, which grow in the
Chinese provinces of Wuminhshan and Gansu, respec-
tively [9]. The related phenolic ether 9 was obtained
from the rhizomatous Heliopsis helianthoides, collected
in Mexico [10]. However, high concentrations of some
of these benzofurans were found in the leaves, probably
reflecting their defensive role against herbivorous
insects. Finally, the 4,6-dimethoxy derivative 10 was iso-
lated from the little shrub Calea peckii grown in Costa
Rica [11].
On the other hand, the related 7-chloro derivative 11
was employed as key intermediate for the synthesis of
analogs of the antifungal agent, griseofulvin [12], and the
4-hydroxy compound 12 was synthesized as an intermedi-
ate toward heterocyclic derivatives containing polysubsti-
tuted alkyl ethers that have been patented as antitumor
and antimetastatic agents, with activity against the uroki-
nase-type plasminogen activator (uPA) [13].
Another member of this family is the linear furo-
coumarin 13, which was obtained from the related, natu-
rally occurring peucedanin and oreoselone [14], and was
employed as an intermediate toward the synthesis of
polyazamacrocycles.
In addition, the 2-isopropylidene-substituted hetero-
cyclic motif has also been found among the fungal
metabolites, pseudodeflectusin (14), ustusorane C (15),
pergillin (16), penicisochroman A (17), and ustusorane A
(18), as well as among other ustusoranes. Finally, the fea-
ture is also characteristic of the much studied furo[3,2-h]
isoquinoline alkaloid TMC-120B (19) [15].
Pseudodeflectusin (14) was isolated from the fungus
Aspergillus pseudodeflectus and from the sea fan-derived
fungus Penicillium sp. PSU-F40. The natural product
exhibits cytotoxicity toward several human cancer cell
lines. On the other hand, tricycle 19 was isolated from
Aspergillus ustus TC 1118 and has shown moderate inhibi-
tory activity against the interleukin-5 mediated prolonga-
tion of eosinophil survival [16]. Further, we have recently
reported that aspergillitine, the alkaloid obtained from
Aspergillus versicolor, isolated from the marine sponge
Xestospongia exigua, to which an angular tricyclic chro-
monic skeleton was assigned, is actually TMC-120B [17].
The interesting bioactivity of the latter compounds has
attracted considerable attention, and their total syntheses
have been reported [18].
In view of the widespread occurrence of the 2-isopro-
pylidenecoumaranone motif among natural products and
taking into account our previous efforts related to TMC-
120B [17], herein, we report an efficient approach toward
6-bromo-2-isopropylidenecoumaranone (20) from 3-bro-
mophenol (21). The former is a potential intermediate
toward pseudodeflectusin (14), related natural products
(15 – 18) and alkaloid TMC-120B (19).
Results and Discussion
The synthesis was initiated with the transformation of com-
mercial 3-bromophenol (21) into the known salicylalde-
hyde derivative 22 [19] (Scheme). The reaction, following
Casiraghi’s protocol [20] with paraformaldehyde in reflux-
ing toluene under SnCl4 catalysis, afforded the aldehyde in
27% yield; however, better results (75%) were obtained
under the conditions of Skatebol [21] with paraformalde-
hyde, strictly anhyd. MgCl2, and Et3N, in refluxing THF.
Despite other alternatives are available that would
require extensive protection and deprotection steps [22],
it was opted to access the cyclized product 24 more
directly, by way of an aldol reaction. To that end, the
Williamson etherification of aldehyde 22 was performed
with freshly prepared monochloroacetone [23] in acetone,
employing K2CO3 as base.
To be successful, the reaction had to be conducted at
temperatures below 40 °C, in order to avoid reduced
yields due to the concomitant uncontrolled base-catalyzed
cyclization of the resulting acetonyl ether to afford alco-
hol 24 and its diasteromer 24a, and the generation of
unwanted side products [24]. Under these conditions, the
yield of 23 was 82%.
The next step was the 5-enolexo-exo-trig aldolization
process toward 24. In order to have better control of the
cyclization, the O-acetonylsalicylaldehyde 23 was exposed
to catalytic amounts of L-proline in DMF, to which 1.0
equivalent of H2O was added. These conditions furnished
84% of aldol 24 as a single diasteromer, after 36 h at
room temperature [25]. The stereochemistry of the result-
ing solid product was ascertained as cis by analysis of the
coupling constants between H–C(2) and H–C(3)
(J = 6.6 Hz).
It was postulated that the reaction may proceed
through an intramolecular version of a Houk–List-type
transition-state model; this may explain the cis-configura-
tion observed [25].
Interestingly, carrying the cyclization reaction in the
presence of catalytic amounts of K2CO3 enabled the for-
mation of inseparable mixtures of cyclized products,
containing variable amounts of the anti-isomer 24a
(JH–C(2) – H–C(3) = 4.5 Hz). The latter proved to be unsta-
ble, becoming dehydrated at room temperature with rela-
tive ease.
Next, the installation of the isopropylidene feature
was undertaken, and a Grignard addition-alcohol elimina-
tion sequence seemed to be the most straightforward
approach. However, this transformation proved challeng-
ing from the beginning, due to the instability [26] and
poor solubility of the starting material in the reaction
medium, in addition, to the marked proneness to enoliza-
tion of the carbonyl moiety.
Thus, the reaction of 24 with MeMgI gave 26% of
diol 25 when performed in Et2O at 78 °C for 30 min.
(Table, Entry 1). Increasing the temperature to 50 °C
proved to be detrimental to the yield, despite 4.0 equiv-
alents MeMgI were added (Entry 2). However, using
diglyme as solvent afforded 31% of the expected diol
after 60 min at 0 °C (Entry 3) and running the transfor-
mation in Et2O/diglyme in the presence of 1.0 equiva-
lent of Bu4NBr as additive, the outcome to 49% yield
of 25 (Entry 4) was improved. A further improvement
to 54% was achieved when 1.1 equivalents of LiCl was
added (Entry 5).
Table. Grignard addition to the carbonyl moieties of 24 and 27
Entry MeMgI [equiv.] Solvent Additive [equiv.] Temp. [°] Time [min] Prod. Yield [%]
1 2.0 Et2O – 78 30 25 26
2 4.0 Et2O – 50 30 25 10
3 3.0 Diglyme – 0 60 25 31
4 3.0 Et2O/Diglyme Bu4NBr (1.0) 0 90 25 49
5 2.0 Et2O/Diglyme Bu4NBr (1.0), LiCl (1.1) 0 30 25 54
6 2.0 Et2O CeCl3 (1.0) 0 30 29 90
7a) 3.0 Et2O – 20 30 28 89
a) The reaction was performed with THP ether 27.
Scheme. Synthesis of 6-bromo-2-isopropylidenecoumaranone (20).
This reagent mixture enabled to activate the C=O
group, improve substrate solubility, and optimize Grig-
nard reactivity [27]. However, the use of 1.0 equivalents
of anhyd. CeCl3 gave 90% of benzofuran 29 as the sole
product (Entry 6).
However, due to the not so unexpected instability of
the 1,3-diol 25 and in order to ensure access to a stable
heterocycle, the latter was immediately subjected to a
Jones’ oxidation at 20 °C, which enabled to get the
ketone 26 in 70% yield.
This outcome prompted to explore modifications in
the reaction conditions toward 26. In order to increase
the solubility of the substrate, alcohol 24 was tetrahy-
dropyranylated under mild standard conditions to afford
70% of the diasteromeric THP-ethers 27, which without
separation furnished 89% yield of the expected com-
pound 28 upon exposure to MeMgI at 20 °C during
30 min (Entry 7). The spectral complexities of the latter
were simplified after reaction with Jones’ reagent, which
enabled in situ deprotection of the THP-ether moiety
and oxidation of the benzylic alcohol, providing 70%
of 26.
To end the proposed synthesis, dehydration of aldol
26 was required. The use of dimethylformamide dimethyl
acetal smoothly furnished 54% yield of 20 after refluxing
in Et2O for 42 h [28]. However, the transformation exhib-
ited poor reproducibility and was difficult to be scaled-up,
probably due to its ability to form a vinylogous enami-
none from the resulting vinylogous methyl ketone prod-
uct. Luckily, slightly better but highly reproducible yields
(61%) were achieved with the use of the MsCl/pyridine
reagent system at 40 °C [29].
Interestingly, a Pd-catalyzed reaction of iodoarenes
with 3-aryl-1-(2-tert-butyldimethylsilyloxy)phenyl-2-pro-
pyn-1-ones toward differentially substituted 2-alkylidene-
coumaranones has also been reported [30]. However, the
only example given on the use of 3-alkyl instead of 3-aryl
substituted starting materials, afforded a 2-alkyl chrome-
none instead of the expected 2-alkylidenecoumaranone,
being this approach unsuitable for targets like 20.
Conclusions
A straightforward synthesis of 6-bromo-2-isopropylidene
coumaranone (20) as a potential key intermediate toward
pseudodeflectusin (14), its congeneric angular tricyclic
naturally occurring coumaranones 15 – 18, and alkaloid
TMC-120B (19), was carried out. The synthesis featured
an L-proline-catalyzed aldolization to form the hetero-
cyclic ring, and a Grignard addition – alcohol oxidation
and dehydration sequence in order to install the isopropy-
lidene side chain. The OH group protection of the aldol
intermediate enabled an improved yield of the final prod-
uct. The synthesis took place in seven steps and 13.7%
overall yield from the commercially available 3-bromo-
phenol (21), or six steps and 10.8% yield, when omitting
the protection stage.
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Experimental Part
General
All the reactions were carried out under dry N2 or Ar
atmospheres, employing oven-dried glassware. Anhyd.
THF, anhyd. Et2O, and anhyd. diglyme were obtained by
reflux of the AR solvent over Na metal (benzophenone as
indicator), followed by distillation. Anhys. CH2Cl2 were
obtained from a solvent purification and dispenser system
(M. Braun, Stratham, New Hampshire, USA). Anhyd. ace-
tone was prepared by refluxing 4 h the AR grade product
over K2CO3 and distilling the solvent at atmospheric pres-
sure. Anhyd. Et3N was prepared by a 4 h reflux of the sol-
vent over CaH2 followed by atmospheric pressure
distillation. Abs. EtOH was prepared by refluxing the pro-
duct over Mg turnings to which a crystal of iodine was
added, and distilling the solvent from the so formed mag-
nesium ethoxide. All other reagents were used as received.
M.p.: Ernst Leitz (Wetzlar, Germany) model 350 hot-stage
microscope and are reported uncorrected.
Chromatographic Methods
The flash column chromatographies were run with silica
gel 60 H (SiO2; Merck, Darmstadt, Germany), eluting with
hexane/AcOEt mixtures, under positive pressure and
employing gradient of solvent polarity techniques. All new
compounds gave single spots on TLC plates (silica gel 60
GF254) run in different hexane/AcOEt solvent systems.
The chromatographic spots were detected by exposure to
254 nm UV light, followed by spraying with ethanolic p-
anisaldehyde/H2SO4 reagent and final careful heating of
the plates for improving selectivity. IR spectra: Shimadzu
Prestige 21 (Shimadzu, Kyoto, Japan) IR spectrophotome-
ter, as thin films held between NaCl cells for oils or as solid
dispersions in KBr disks, for solid samples. Absorption fre-
quencies (m) are in cm1. 1H-NMR spectra: 300.13 MHz in
CDCl3 on a Bruker Avance
TM 300 (Bruker, Rheinstetten,
Germany) NMR spectrometer. Chemical shifts are
reported in ppm on the d scale; w1/2 and J-values are given
in Hz. The residual solvent peak (CHCl3 in CDCl3, d(H)
7.26) was used as the internal standard. 13C-NMR spectra
were recorded at 75.48 MHz on a Bruker Avance spec-
trometer. The solvent peak (CDCl3, d(C) 77.0) was used as
the internal standard. In special cases, 2D-NMR experi-
ments (HMBC and HSQC) were also employed to aid the
interpretation and assignment of the spectra. HR-MS: Bru-
ker MicroTOF-Q II instrument (Bruker Daltonics, Biller-
ica, MA, USA). Detection of the ions was performed in
electrospray ionization, positive ion mode.
4-Bromo-2-hydroxybenzaldehyde (22). A solution of
3-bromophenol (21, 1100 mg, 6.3 mmol) and anhyd. Et3N
(1.8 ml) in dry THF (13 ml) was treated with anhyd.
MgCl2 (1200 mg, 12.6 mmol). After stirring for 10 min.,
(CHO)n (572 mg, 18.69 mmol) was added and heated
under reflux for 10 h. The mixture was then cooled to
room temperature, 5% aq. HCl was added, and the pro-
duct extracted with CH2Cl2. The combined organic
extracts were washed with brine, dried (Na2SO4), and
concentrated under reduced pressure. The chromatogra-
phy of the residue gave 22 (950 mg, 75%), as a pale yel-
low solid. M.p.: 42 °C. Lit.: 50 – 51.5 °C [21]. Rf = 0.66;
hexane/AcOEt 85:15. IR (KBr): 3381, 2924, 2850, 1651,
1557, 1479, 1304, 1188, 1067, 907, 862, 799. 1H-NMR:
11.11 (s, 1 H, OH); 9.85 (s, 1 H, COH); 7.41 (d, J = 8.1, 1
H, H–C(6)); 7.19 (d, J = 1.6, 1 H, H–C(3)); 7.16 (dd,
J = 8.1, 1.6, 1 H, H–C(5)). 13C-NMR: 195.8 (COH); 161.9
(C(2)); 134.5 (C(6)); 132.0 (C(4)); 123.5 (C(5)); 121.1 (C
(3)); 119.5 (C(1)).
4-Bromo-2-(2-oxopropoxy)benzaldehyde (23). A solution
of aldehyde 22 (800 mg, 3.11 mmol) in dry acetone was
treated with K2CO3 (644 mg, 4.67 mmol), ClCH2COMe
(2.42 ml, 4.04 mmol), and a catalytic amount of KI. The
reaction was stirred for 4 h at 30 °C. After cooling to
room temperature, the K2CO3 was filtered off, the solvent
was evaporated, and the residue was chromatographed,
furnishing compound 23 (655 mg, 82%), as a yellow oil.
Rf = 0.22; hexane/AcOEt 85:15. IR (film): 3454, 1732,
1680, 1587, 1406, 1246, 1064, 889. 1H-NMR: 10.48 (s, 1 H,
COH); 7.73 (d, J = 8.4, 1 H, H–C(6)); 7.24 (dd, J = 8.4,
1.5, 1 H, H–C(5)); 6.97 (d, J = 1.5, 1 H, H–C(3)); 4,69 (s,
2 H, CH2COCH3); 2.33 (s, 3 H, CH2COCH3).
13C-NMR:
202.8 (CH2COCH3); 189.0 (COH); 159.9 (C(2)); 132.5 (C
(4)); 130.4 (C(6)); 125.5 (C(5)); 124.0 (C(1)); 116.6 (C(3));
73.2 (CH2COCH3); 26.7 (CH2COCH3). HR-ESI-TOF-
MS: 278.9621 ([M+Na]+, C10H9BrNaO
þ
3 ; calc. 278.9633).
1-[(2R*,3S*)-6-Bromo-2,3-dihydro-3-hydroxy-1-benzofuran-
2-yl]ethanone (24). To a solution of 23 (500 mg,
1.95 mmol) in DMF (8.3 ml) was added H2O (0.035 ml,
1.95 mmol) and L-proline (44 mg, 0.39 mmol). The mixture
was stirred for 30 h at room temperature. After addition
of brine (10 ml), the product was extracted with AcOEt
(4 9 25 ml). The organic extracts were combined, succes-
sively washed with H2O (5 9 10 ml) and brine (10 ml),
dried (Na2SO4), and concentrated under reduced pressure.
Chromatography of the residue gave 24 (421 mg, 84%), as
a white solid. M.p.: 130 – 132 °C (hexane/AcOEt).
Rf = 0.39; hexane/AcOEt 70:30. IR (KBr): 3439, 1714,
1604, 1448, 1286, 1180, 897. 1H-NMR: 7.28 (d, J = 7.2, 1
H, H–C(4)); 7.15 (d, J = 1.7, 1 H, H–C(7)); 7.13 (dd,
J = 7.2, 1.7, 1 H, H–C(5)); 5.50 (d, J = 6.6, 1 H, H–C(3));
4.96 (d, J = 6.6, 1 H, H–C(2)); 2.35 (s, 3 H, COCH3); 1.55
(br. s, 1 H, OH). 13C-NMR: 205.8 (COCH3); 160.4 (C
(7a)); 126.9 (C(4)); 126.0 (C(3a)); 125.2 (C(5)); 124.6 (C
(6)); 114.5 (C(7)); 90.7 (C(2)); 72.4 (C(3)); 28.5 (COCH3).





2-yl]ethanone (24a). K2CO3 (7 mg, 0.05 mmol) was added
to a solution of 23 (50 mg, 0.20 mmol) in AcOEt (25 ml),
and the solvent was slowly evaporated in a rotary evapo-
rator at 40 °C. AcOEt (10 ml) was added to the residue,
the solid was filtered off, and the solvent was evaporated
under reduced pressure. The residue was chro-
matographed, furnishing an inseparable mixture of
cyclized compounds containing 24 and 24a (35 mg, 70%),
as an oil. Compound 24a: Rf = 0.39; hexane/AcOEt 70:30.
1H-NMR: 7.24 (d, J = 8.0, 1 H, H–C(4)); 7.14 (d, J = 1.5,
1 H, H–C(7)); 7.14 (dd, J = 8.0, 1.5, 1 H, H–C(5)); 5.50
(br. d, J = 4.5, 1 H, H–C(3)); 4.89 (d, J = 4.5, 1 H, H–C
(2)); 2.25 (s, 3 H, COCH3); 1.55 (br. s, 1 H, OH).
13C-
NMR: 206.4 (COCH3); 160.1 (C(7a)); 125.2 (C(4)); 126.0
(C(3a)); 125.2 (C(5)); 124.5 (C(6)); 114.4 (C(7)); 94.6 (C
(2)); 74.6 (C(3)); 26.6 (COCH3). HR-ESI-TOF-MS:
278.9628 ([M + Na]+, C10H9BrNaO
þ
3 ; calc. 278.9633).
6-Bromo-2,3-dihydro-2-(1-hydroxypropan-2-yl)-1-benzo-
furan-3-ol (25). A mixture of MeMgI (1.5 ml, 1.38 mmol),
Bu4NBr (27 mg, 0.092 mmol), and LiCl (21 mg,
0.51 mmol) in a mixture of anhyd. Et2O (1.4 ml) and
anhyd. diglyme (0.17 ml, 1.14 mmol) was stirred for
30 min at 0 °C. Then, a solution of methyl ketone 24
(125 mg, 0.46 mmol) in ether (0.5 ml) was added and the
mixture was allowed to warm to room temperature. After
1 h, the reaction was quenched with saturated solution of
NH4Cl (5 ml) and extracted with CH2Cl2 (4 9 20 ml).
The combined organic extracts were washed with brine
(10 ml), dried (Na2SO4), and concentrated under reduced
pressure. The residue was chromatographed, affording
diol 25 (68 mg, 54%) as a brownish oil. Rf = 0.21; hexane/
AcOEt 70:30. IR (film): 3377, 2924, 1603, 1472, 1225,
1005, 893. 1H-NMR: 7.26 (d, J = 7.5, 1 H, H–C(4)); 7.08
(dd, J = 7.5, 1.7, 1 H, H–C(5)); 7.06 (d, J = 1.7, 1 H, H–C
(7)); 5.27 (d, J = 6.2, 1 H, H–C(3)); 4.24 (d, J = 6.2, 1 H,
H–C(2)); 4.03 (br. s, 1 H, OH–C(3)); 2.71 (br. s, 1 H, C
(CH3)2OH); 1.56 (s, 3 H, COHCH3); 1.50 (s, 3 H,
COHCH3).
13C-NMR: 160.2 (C(7a)); 129.2 (C(3a)); 126.5
(C(4)); 124.6 (C(5)); 123.7 (C(6)); 114.1 (C(7)); 89.7 (C
(2)); 72.8 (COHCH3); 72.4 (C(3)); 28.4 (COHCH3); 25.3




3 ; calc. 294.9946).
2-(6-Bromo-1-benzofuran-2-yl)propan-2-ol (29). To a solu-
tion of 24 (100 mg, 0.39 mmol) in ether (3 ml) was slowly
added at 0 °C MeMgI (0.95 ml, 0.78 mmol) and CeCl3
(96 mg, 0.39 mmol). After stirring the reaction at 0 °C for
30 min it was quenched with NH4Cl (5 ml) and extracted
with CH2Cl2 (4 9 20 ml). The combined organic extracts
were washed with brine (10 ml), dried (Na2SO4), and con-
centrated under reduced pressure. The residue was chro-
matographed, affording 29 (89.5 mg, 90%) as a brownish
oil. Rf = 0.52; hexane/AcOEt 70:30. IR (film): 3381.2,
2982.0, 1606.7, 1452.0, 1273.0, 1168.9, 898.8. 1H-NMR:
7.61 (d, J = 1.6 Hz, 1 H, H–C(7)); 7.38 (d, J = 8.3, 1 H,
H–C(4)); 7.32 (dd, J = 8.3, 1.6, 1 H, H–C(5)); 6.54 (s, 1
H, H–C(3)); 2.19 (br. s, w1/2 = 25 Hz, 1 H, OH); 1.66 (s, 6
H, COH(CH3)2).
13C-NMR: 163.7 (C(2)); 155.0 (C(7a));
127.4 (C(3a)); 126.1 (C(5)); 121.9 (C(4)); 117.1 (C(6));
114.7 (C(7)); 100.3 (C(3)); 69.3 (COHCH3); 28.7
(COHCH3); 28.7 (COHCH3). HR-ESI-TOF-MS: 292.9786
([M+Na]+, C11H11BrNaO
þ
2 ; calc. 276.9840).
6-Bromo-2-(1-hydroxypropan-2-yl)-1-benzofuran-3(2H)-one
(26). Method A: A solution of chromium trioxide and sul-
furic acid in acetone (Jones’ reagent, 0.083 ml, 0.66 mmol)
was slowly added to a stirred solution of diol 25 (60 mg,
0.22 mmol) in acetone (6 ml), cooled at 20 °C. The reac-
tion was allowed to warm to 0 °C and the excess of Jones
reagent was quenched with isopropyl alcohol. Then, the
pH of the solution was adjusted to 4.0 with a saturated
solution of NaOAc, the solvent was evaporated under
reduced pressure and the product extracted with Et2O
(4 9 20 ml). The combined organic extracts were washed
with brine (5 ml), dried (Na2SO4), and concentrated under
reduced pressure. Chromatography of the residue provided
the ketone 26 (42 mg, 70%) as a brownish oil. Rf = 0.47;
hexane/AcOEt 70:30. IR (film): 3418, 2926, 1713, 1601,
1427, 1315, 1198, 1016, 883. 1H-NMR: 7.51 (d, J = 8.4, 1 H,
H–C(4)); 7.37 (d, J = 1.4, 1 H, H–C(7)); 7.24 (dd, J = 8.4,
1.4, 1 H, H–C(5)); 4.39 (s, 1 H, H–C(2)); 2.96 (br. s, 1 H,
OH); 1.35 (s, 3 H, COHCH3); 1.24 (s, 3 H, COHCH3).
13C-NMR: 199.8 (C(3)); 172.9 (C(7a)); 133.2 (C(6)); 126.2
(C(5)); 125.1 (C(4)); 120.1 (C(3a)); 117.0 (C(7)); 89.8 (C
(2)); 72.4 (COHCH3); 25.6 (COHCH3); 24.3 (COHCH3).





(26). Method B: Dihydropyran (0.08 ml, 0.88 mmol), cam-
phorsulfonic acid (6.8 mg, 0.030 mmol), and powdered
4 A molecular sieves (100 mg) were successively added to
a solution of 24 (150 mg, 0.59 mmol) in CH2Cl2 (6 ml).
The reaction was stirred at room temperature for 2 h,
when brine (7 ml) was added, and the product was
extracted with AcOEt (4 9 20 ml). The combined organic
extracts were washed with brine (5 ml), dried (Na2SO4),
and concentrated under reduced pressure. The residue was
chromatographed, giving 27 (140 mg, 70%) as a brownish
oil. Rf = 0.68; hexane/AcOEt 70:30. IR (film) 2941, 1725,
1600, 1473, 1356, 1219, 1118, 1020, 891. 1H-NMR: 7.28 (d,
J = 8.4, 1 H, H–C(4)); 7.22 (d, J = 7.9, 1 H, H–C(4)); 7.15
(m, 1 H, H–C(7)); 7.12 (m, 1 H, H–C(5)); 5.42 (d, J = 7.4,
1 H, H–C(3)); 5.41 (d, J = 6.4, 1 H, H–C(3)); 4.95 (d,
J = 6.4, 1 H, H–C(2)); 4.91 (d, J = 7.4, 1 H, H–C(2)); 3.67
(m, 2 H, H–C(60)); 2.36 (s, 3 H, COCH3); 2.28 (s, 3 H,
COCH3); 1.55 (m, 2 H, H–C(50); 1.53 (m, 2 H, H–C(40);
1.51 (m, 2 H, H–C(30). 13C-NMR: 206.2 (COCH3); 204.3
(COCH3); 161.2 (C(7a)); 160.7 (C(7a)); 128.1 (C(4)); 127.9
(C(3a)); 127.3 (C(3a)); 127.2 (C(4)); 125.3 (C(6)); 124.9 (C
(5)); 124.7 (C(6)); 124.4 (C(5)); 114.7 (C(7)); 114.2 (C(7));
100.5 (C(20)); 93.3 (C(20)); 90.1 (C(2)); 89.7 (C(2)); 78.9 (C
(3)); 73.1 (C(3)); 62.6 (C(30)); 61.7 (C(30)); 30.3 (C(60));
29.8 (C(60)); 28.2 (COCH3); 28.1 (COCH3); 25.2 (C(50));
19.0 (C(40)); 18.4 (C(40)). HR-ESI-TOF-MS: 363.0202
([M+Na]+, C15H17BrNaO
þ
4 ; calc. 363.0208).
A solution of MeMgI (0.65 ml, 0.56 mmol), in Et2O
(0.6 ml) was slowly added at 20 °C to a solution of the
methyl ketone 27 (125 mg, 0.37 mmol) in anhyd. Et2O
(0.4 ml) and the mixture was allowed to warm to room
temperature. After 1 h, the reaction was quenched with
NH4Cl (5 ml) and extracted with CH2Cl2 (4 9 20 ml).
The pooled organic extracts were washed with brine
(5 ml), dried (Na2SO4), and concentrated under reduced
pressure. The residue was chromatographed to yield alco-
hol 28 (118 mg, 89%) as a brownish oil. Rf = 0.37; hex-
ane/AcOEt 80:20. HR-ESI-TOF-MS: 379.0511 ([M+Na]+,
C16H21BrNaO
þ
4 ; calc. 379.0515).
A solution of Jones’ reagent (0.124 ml, 0.93 mmol)
was slowly added to a stirred solution of protected alco-
hol 28 (110 mg, 0.31 mmol) in acetone (9 ml), cooled at
20 °C. The reaction was allowed to warm to 0 °C and
the excess of Jones’ reagent was quenched with iPrOH.
Then, the pH of the solution was adjusted to 4.0 with a
saturated solution of AcONa, the solvent was evaporated
under reduced pressure, and the product extracted with
Et2O (4 9 20 ml). The combined organic extracts were
washed with brine (5 ml), dried (Na2SO4), and concen-
trated under reduced pressure. The chromatography of
the residue provided the ketone 26 (59 mg, 70%) as a
brownish oil. The NMR and IR data of the product were
in agreement with those recorded for 26, when obtained
from 25.
6-Bromo-2-(propan-2-ylidene)-1-benzofuran-3(2H)-one (20).
A solution of MsCl in CH2Cl2 (2M, 0.9 ml, 1.8 mmol) was
dropwise added to a stirred solution of ketone 26 (50 mg,
0.18 mmol) and DMAP (4.5 mg, 0.04 mmol) in anhyd. pyr-
idine (0.3 ml). The reaction was further stirred for 17 h at
40 °C, when it was cooled to room temperature and the
pH was adjusted to 4 – 5 with a solution of HCl (10% w/
v). Then, the product was extracted with CH2Cl2
(4 9 20 ml), the combined organic extracts were washed
with water (5 ml), dried (Na2SO4), and concentrated under
reduced pressure. The chromatography of the residue gave
the coumaranone derivative 20 (25 mg, 61%) as a yellowish
solid. M.p.: 43 – 45 °C. Rf = 0.79; hexane/AcOEt 70:30. IR
(KBr): 2924, 2359, 1745, 1703, 1651, 1599, 1427, 1313, 1117,
899. 1H-NMR: 7.60 (d, J = 8.3, 1 H, H–C(4)); 7.40 (d,
J = 1.6, 1 H, H–C(7)); 7.27 (dd, J = 8.3, 1.6, 1 H, H–C(5));
2.35 (s, 3 H, CH3); 2.09 (s, 3 H, CH3).
13C-NMR: 182.7 (C
(3)); 164.5 (C(7a)); 145.0 (C(2)); 130.5 (C(6)); 126.0 (C(5));
125.2 (C(4)); 122.5 (C(3a)); 116.1 (C(7)); 133.1 (C(CH3)2);
20.2 (CH3); 17.5 (CH3). HR-ESI-TOF-MS: 274.9667
([M+Na]+, C11H9BrNaO
þ
2 ; calc. 274.9684).
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